semaglutide glp 1 receptor agonist The Landscape Of GLP-1 Agonists In Diabetes And Obesity Treatment glp-1_analogs [TUSOM | Pharmwiki]

Zhou Y, Teng X, Han M, Shi J, Li C, Zhang X, et al

This treatment also led to a decrease in nitrogen balance and reduced nitrogen content in various organs

By integrating advances in neuroscience, pharmacology, and molecular medicine, this review emphasizes the promise of Nrf2 as a unifying therapeutic target across diverse CNS pathologies

SMAD7 functions as an inhibitory SMAD that competes with R-SMADs for receptor binding, thereby negatively regulating the pathway [40]

Tau in Alzheimer disease and related tauopathies

demonstrated that sodium butyrate elevates intracellular calcium through store-operated calcium entry, thereby activating AMPK in a calcium-dependent manner